Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Tables)

Common Shares and Warrants (Tables)

3 Months Ended

Nov. 30, 2021

Common Shares and Warrants

Schedule of fair value of purchase warrants

Sehedule of warrants

Schedule of warrants issued

		Number of Warrants				Weighted Average Exercise Price $
Balance August 31, 2020			471,608				16.77
Cancelled/expired			(44,161	)			67.50
Exercised			(610,189	)			6.58
Issued			2,630,017				6.58
Balance August 31, 2021			2,447,275				8.00
Cancelled/expired			(25,292	)			4.57
Balance November 30, 2021			2,421,983				8.04

Schedule of warrants outstanding

# of Warrants	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price $
7,500	0.96 years	24.00
100,000	2.38 years	9.00
200,000	2.38 years	7.00
51,814	2.96 years	36.00
8,984	3.00 years	36.00
16,667	3.29 years	9.00
317,190	3.43 years	10.50
1,719,828	4.13 years	6.58
2,421,983	3.86 years	8.04